Revision Year: 2022 Publisher: <u>Owner and Operator abroad:</u> FRILAB SA, 17, rue des Pierres du Niton, 1207, Genève, SWITZERLAND Made by Laboratoires TERIAK, ZI Jebel Ouest Tunisia
Anticholinergic preferably acting at muscarinic receptors in the gastrointestinal tract. Corrects chlorhydropeptique hypersecretion, gastrin, pancreatic.
Corrects hypermotility of the gastrointestinal tract. Administered orally, it respects gastric emptying and allows elementary motor activity of the digestive smooth fiber.
Absorbed from the gastrointestinal tract, prifinium bromide preferentially distributes in the gastrointestinal tract. It is eliminated mainly via the bile and gut secretions.
The massive or parenteral administration can lead to action on other devices such as the eye, heart, salivary glands.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
